Last reviewed · How we verify

Aplisol — Competitive Intelligence Brief

Aplisol (TUBERCULIN) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Skin Test Antigen [EPC]. Area: Immunology.

marketed Skin Test Antigen [EPC] Immunology Live · refreshed every 30 min

Target snapshot

Aplisol (TUBERCULIN) — ENDO USA, Inc..

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Aplisol TARGET TUBERCULIN ENDO USA, Inc. marketed Skin Test Antigen [EPC]
Tuberculin purified protein derivative Tuberculin purified protein derivative Assiut University marketed Skin Test Antigen [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Skin Test Antigen [EPC] class)

  1. Assiut University · 1 drug in this class
  2. ENDO USA, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aplisol — Competitive Intelligence Brief. https://druglandscape.com/ci/tuberculin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: